Improving the efficacy of antibody-based cancer therapies

作者: Paul Carter

DOI: 10.1038/35101072

关键词: ImmunologyClinical trialRadioimmunotherapyRituximabImmunizationTrastuzumabMedicineMonoclonal antibodyAntigenCancerIntensive care medicineCancer researchOncology

摘要: … Interactions between antibody Fc regions and their Fcγ receptors are crucial to the in vivo … , by cellular engineering of antibody production hosts to manipulate antibody glycoforms. …

参考文章(138)
Epenetos Aa, Syrigos Kn, Antibody directed enzyme prodrug therapy (ADEPT): a review of the experimental and clinical considerations. Anticancer Research. ,vol. 19, pp. 605- 613 ,(1999)
ME Reff, K Carner, KS Chambers, PC Chinn, JE Leonard, R Raab, RA Newman, N Hanna, DR Anderson, Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20 Blood. ,vol. 83, pp. 435- 445 ,(1994) , 10.1182/BLOOD.V83.2.435.435
M D Pegram, R J Pietras, S B Howell, V R Chazin, B M Fendly, D J Slamon, Antibody to HER-2/neu receptor blocks DNA repair after cisplatin in human breast and ovarian cancer cells. Oncogene. ,vol. 9, pp. 1829- 1838 ,(1994)
E.L. Sievers, F.R. Appelbaum, R.T. Spielberger, S.J. Forman, D. Flowers, F.O. Smith, K. Shannon-Dorcy, M.S. Berger, I.D. Bernstein, Selective ablation of acute myeloid leukemia using antibody-targeted chemotherapy: a phase I study of an anti-CD33 calicheamicin immunoconjugate. Blood. ,vol. 93, pp. 3678- 3684 ,(1999) , 10.1182/BLOOD.V93.11.3678.411K24_3678_3684
P. Lorenz, H.H. Sedlacek, J. Czech, C. Kolar, G. Seemann, K. Bosslet, D. Hoffmann, Antibodies as Carriers of Cytotoxicity ,(1992)
Elvin A. Kabat, Sequences of proteins of immunological interest National Institutes of Health. ,(1991)
Richard J. Pietras, David Gallardo, P. Nancy Wongvipat, H. Julie Lee, Joseph C. Poen, Dennis J. Slamon, Monoclonal antibody to HER-2/neureceptor modulates repair of radiation-induced DNA damage and enhances radiosensitivity of human breast cancer cells overexpressing this oncogene. Cancer Research. ,vol. 59, pp. 1347- 1355 ,(1999)
Pablo Umaña, Joël Jean–Mairet, Radmila Moudry, Hanspeter Amstutz, James E. Bailey, Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity Nature Biotechnology. ,vol. 17, pp. 176- 180 ,(1999) , 10.1038/6179
Robert L Shields, Angela K Namenuk, Kyu Hong, Y Gloria Meng, Julie Rae, John Briggs, Dong Xie, Jadine Lai, Andrew Stadlen, Betty Li, Judith A Fox, Leonard G Presta, None, High Resolution Mapping of the Binding Site on Human IgG1 for FcγRI, FcγRII, FcγRIII, and FcRn and Design of IgG1 Variants with Improved Binding to the FcγR Journal of Biological Chemistry. ,vol. 276, pp. 6591- 6604 ,(2001) , 10.1074/JBC.M009483200